Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Litchfield LM"'
Autor:
Goetz MP; Mayo Clinic, Rochester, Minnesota., Hamilton EP; Sarah Cannon Research Institute, Tennessee Oncology PLCC, Nashville, Tennessee., Campone M; Institut de Cancerologie de l'Ouest, Angers Cedex, France., Hurvitz SA; University of California, Los Angeles, California., Cortes J; Oncology Department, International Breast Cancer Center (IBCC), Pangaea Oncology, Quiron Group, Barcelona, Spain.; Department of Medicine, Universidad Europea de Madrid, Faculty of Biomedical and Health Sciences, Madrid, Spain., Johnston S; The Royal Marsden NHS Foundation Trust, London, United Kingdom., Llombart-Cussac A; Hospital Arnau Vilanova, Valencia, Spain., Kaufman PA; University of Vermont Medical Center, Burlington, Vermont., Toi M; Kyoto University, Kyoto, Japan., Jerusalem G; CHU Liege and Liege University, Liege, Belgium., Graham H; Eli Lilly and Company, Indianapolis, Indiana., Wang H; Eli Lilly and Company, Indianapolis, Indiana., Jansen VM; Eli Lilly and Company, Indianapolis, Indiana., Litchfield LM; Eli Lilly and Company, Indianapolis, Indiana., Martin M; Instiuto de Investigacion Santaria Gregorio Maranon, Universidad Complutense, CIBERONC, Madrid, Spain.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 May 15; Vol. 30 (10), pp. 2233-2244.
Autor:
Tolaney SM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Goel S; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.; Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Nadal J; Instituto Alexander Fleming, Buenos Aires, Argentina., Denys H; Department of Medical Oncology, Ghent University Hospital, Ghent, Belgium., Borrego MR; Medical Oncology Department, Hospital Universitario Virgen del Rocio, Seville, Spain., Litchfield LM; Eli Lilly and Company, Indianapolis, Indiana., Liu J; Eli Lilly and Company, Indianapolis, Indiana., Appiah AK; Eli Lilly and Company, Indianapolis, Indiana., Chen Y; Eli Lilly and Company, Indianapolis, Indiana., André F; Institut Gustave Roussy, INSERM Unité 981, Université Paris-Sud, Villejuif, France.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Jan 05; Vol. 30 (1), pp. 39-49.
Autor:
Rao X; Eli Lilly and Company, Indianapolis, Indiana., Chen Y; Eli Lilly and Company, Indianapolis, Indiana., Beyrer J; Eli Lilly and Company, Indianapolis, Indiana., Nash Smyth E; Eli Lilly and Company, Indianapolis, Indiana., Morato Guimaraes C; Eli Lilly and Company, Indianapolis, Indiana., Litchfield LM; Eli Lilly and Company, Indianapolis, Indiana., Bowman L; Eli Lilly and Company, Indianapolis, Indiana., Lawrence GW; Eli Lilly and Company, Indianapolis, Indiana., Aggarwal A; Eli Lilly and Company, Indianapolis, Indiana., Andre F; Université Paris Sud, Orsay, France.; Inserm, Gustave Roussy Cancer Campus, UMR981, Villejuif, France.; Department of Medical Oncology, Gustave Roussy, Villejuif, France.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Sep 01; Vol. 29 (17), pp. 3372-3383.
Autor:
Tolaney SM, Toi M, Neven P, Sohn J, Grischke EM, Llombart-Cussac A, Soliman H, Wang H, Wijayawardana S, Jansen VM, Litchfield LM, Sledge GW
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2022 Oct 14; Vol. 28 (20), pp. 4587.
Autor:
Wander SA; Department of Medical Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA., O'Brien N; Department of Medicine, Division of Hematology/Oncology, Geffen School of Medicine at UCLA, Los Angeles, CA, USA., Litchfield LM; Eli Lilly and Company, Indianapolis, IN, USA., O'Dea D; Eli Lilly and Company, Cork, Ireland., Morato Guimaraes C; Eli Lilly and Company, Indianapolis, IN, USA., Slamon DJ; Department of Medicine, Division of Hematology/Oncology, Geffen School of Medicine at UCLA, Los Angeles, CA, USA., Goel S; Department of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; The Sir Peter MacCallum Department of Oncology, University of Melbourne, VIC, Australia.
Publikováno v:
The oncologist [Oncologist] 2022 Oct 01; Vol. 27 (10), pp. 811-821.
Autor:
Tolaney SM; Dana-Farber Cancer Institute, Boston, Massachusetts., Toi M; Kyoto University, Kyoto, Japan., Neven P; Universitaire Ziekenhuizen Leuven - Campus Gasthuisberg, Leuven, Belgium., Sohn J; Yonsei Cancer Center, Seoul, Korea., Grischke EM; Universitatsklinikum Tubingen Frauenklinik, Tubingen, Germany., Llombart-Cussac A; Hospital Arnau Vilanova, Valencia, Spain., Soliman H; Moffitt Cancer Center, Tampa, Florida., Wang H; Eli Lilly and Company, Indianapolis, Indiana., Wijayawardana S; Eli Lilly and Company, Indianapolis, Indiana., Jansen VM; Eli Lilly and Company, Indianapolis, Indiana., Litchfield LM; Eli Lilly and Company, Indianapolis, Indiana., Sledge GW; Stanford University, Stanford, California.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2022 Apr 14; Vol. 28 (8), pp. 1500-1506.
Autor:
Tolaney SM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States., Beeram M; South Texas Accelerated Research Therapeutics, San Antonio, TX, United States., Beck JT; Department of Medical Oncology and Hematology, Highlands Oncology, Springdale, AR, United States., Conlin A; Providence Cancer Center, Portland, OR, United States., Dees EC; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States., Puhalla SL; UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, United States., Rexer BN; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, United States., Burris HA; Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN, United States., Jhaveri K; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, United States.; Department of Medicine, Weil Cornell Medical College, New York, NY, United States., Helsten T; Moores Cancer Center, University of California San Diego, San Diego, CA, United States., Becerra C; Texas Oncology, Dallas, TX, United States., Kalinsky K; Department of Medicine, Columbia University, New York, NY, United States.; Department of Hematology/Oncology, Emory University Winship Cancer Institute, Atlanta, GA, United States., Moore KN; Stevenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States.; Sarah Cannon Research Institute, Nashville, TN, United States., Manuel AM; Eli Lilly and Company, Indianapolis, IN, United States., Lithio A; Eli Lilly and Company, Indianapolis, IN, United States., Price GL; Eli Lilly and Company, Indianapolis, IN, United States., Chapman SC; Eli Lilly and Company, Indianapolis, IN, United States., Litchfield LM; Eli Lilly and Company, Indianapolis, IN, United States., Goetz MP; Department of Oncology, Mayo Clinic, Rochester, MN, United States.; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, United States.
Publikováno v:
Frontiers in oncology [Front Oncol] 2022 Feb 10; Vol. 11, pp. 810023. Date of Electronic Publication: 2022 Feb 10 (Print Publication: 2021).
Autor:
De Angelis C, Fu X, Cataldo ML, Nardone A, Pereira R, Veeraraghavan J, Nanda S, Qin L, Sethunath V, Wang T, Hilsenbeck SG, Benelli M, Migliaccio I, Guarducci C, Malorni L, Litchfield LM, Liu J, Donaldson J, Selenica P, Brown DN, Weigelt B, Reis-Filho JS, Park BH, Hurvitz SA, Slamon DJ, Rimawi MF, Jansen VM, Jeselsohn R, Osborne CK, Schiff R
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2021 Sep 01; Vol. 27 (17), pp. 4939.
Autor:
De Angelis C; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.; Department of Medicine, Baylor College of Medicine, Houston, Texas.; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.; Department of Clinical Medicine and Surgery, University of Naples 'Federico II', Naples, Italy., Fu X; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas., Cataldo ML; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.; Department of Medicine, Baylor College of Medicine, Houston, Texas.; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.; Department of Clinical Medicine and Surgery, University of Naples 'Federico II', Naples, Italy., Nardone A; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Pereira R; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.; Department of Medicine, Baylor College of Medicine, Houston, Texas.; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas., Veeraraghavan J; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.; Department of Medicine, Baylor College of Medicine, Houston, Texas.; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas., Nanda S; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.; Department of Medicine, Baylor College of Medicine, Houston, Texas.; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas., Qin L; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.; Department of Medicine, Baylor College of Medicine, Houston, Texas.; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas., Sethunath V; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.; Department of Medicine, Baylor College of Medicine, Houston, Texas.; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas., Wang T; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.; Department of Medicine, Baylor College of Medicine, Houston, Texas.; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas., Hilsenbeck SG; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas., Benelli M; 'Sandro Pitigliani' Translational Research Unit, Hospital of Prato, Prato, Italy., Migliaccio I; 'Sandro Pitigliani' Translational Research Unit, Hospital of Prato, Prato, Italy.; 'Sandro Pitigliani' Medical Oncology Department, Hospital of Prato, Prato, Italy., Guarducci C; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; 'Sandro Pitigliani' Translational Research Unit, Hospital of Prato, Prato, Italy., Malorni L; 'Sandro Pitigliani' Translational Research Unit, Hospital of Prato, Prato, Italy.; 'Sandro Pitigliani' Medical Oncology Department, Hospital of Prato, Prato, Italy., Litchfield LM; Eli Lilly and Company, Indianapolis, Indiana., Liu J; Eli Lilly and Company, Indianapolis, Indiana., Donaldson J; Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee., Selenica P; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York., Brown DN; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York., Weigelt B; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York., Reis-Filho JS; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York., Park BH; Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee., Hurvitz SA; University of California, Los Angeles, Los Angeles, California., Slamon DJ; University of California, Los Angeles, Los Angeles, California., Rimawi MF; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.; Department of Medicine, Baylor College of Medicine, Houston, Texas.; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas., Jansen VM; Eli Lilly and Company, Indianapolis, Indiana., Jeselsohn R; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Osborne CK; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas.; Department of Medicine, Baylor College of Medicine, Houston, Texas.; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas., Schiff R; Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas. rschiff@bcm.edu.; Department of Medicine, Baylor College of Medicine, Houston, Texas.; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2021 Sep 01; Vol. 27 (17), pp. 4870-4882. Date of Electronic Publication: 2021 Feb 03.
Autor:
Wander SA; Center for Cancer Precision Medicine, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Cohen O; Center for Cancer Precision Medicine, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Gong X; Eli Lilly and Co., Indianapolis, Indiana., Johnson GN; Center for Cancer Precision Medicine, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Buendia-Buendia JE; Center for Cancer Precision Medicine, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Lloyd MR; Center for Cancer Precision Medicine, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Kim D; Center for Cancer Precision Medicine, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Luo F; Center for Cancer Precision Medicine, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Mao P; Center for Cancer Precision Medicine, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Helvie K; Center for Cancer Precision Medicine, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Kowalski KJ; Center for Cancer Precision Medicine, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Nayar U; Center for Cancer Precision Medicine, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Waks AG; Center for Cancer Precision Medicine, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Parsons SH; Eli Lilly and Co., Indianapolis, Indiana., Martinez R; Eli Lilly and Co., Indianapolis, Indiana., Litchfield LM; Eli Lilly and Co., Indianapolis, Indiana., Ye XS; Eli Lilly and Co., Indianapolis, Indiana., Yu C; Eli Lilly and Co., Indianapolis, Indiana., Jansen VM; Eli Lilly and Co., Indianapolis, Indiana., Stille JR; Eli Lilly and Co., Indianapolis, Indiana., Smith PS; Eli Lilly and Co., Indianapolis, Indiana., Oakley GJ; Eli Lilly and Co., Indianapolis, Indiana., Chu QS; Cross Cancer Institute, Alberta, Canada., Batist G; Segal Cancer Centre, Jewish General Hospital, McGill University, Montreal, Canada., Hughes ME; Center for Cancer Precision Medicine, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Kremer JD; Eli Lilly and Co., Indianapolis, Indiana., Garraway LA; Center for Cancer Precision Medicine, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Eli Lilly and Co., Indianapolis, Indiana., Winer EP; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Tolaney SM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Lin NU; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Buchanan SG; Eli Lilly and Co., Indianapolis, Indiana., Wagle N; Center for Cancer Precision Medicine, Dana-Farber Cancer Institute, Boston, Massachusetts. nikhil_wagle@dfci.harvard.edu.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.
Publikováno v:
Cancer discovery [Cancer Discov] 2020 Aug; Vol. 10 (8), pp. 1174-1193. Date of Electronic Publication: 2020 May 13.